Deniz ASLAN, Najim AMEZİANE, Johan P De WİNTER

Molecular diagnosis of Fanconi anemia with next-generation sequencing in a case with subtle signs and a negative chromosomal breakage test

Aslan D, Ameziane N, De Winter JP. Molecular diagnosis of Fanconi anemia with next-generation sequencing in a case with subtle signs and a negative chromosomal breakage test. Turk J Pediatr 2015; 57: 282-285. Fanconi anemia (FA) is an inherited disorder characterized by malformations, marrow failure, and predisposition to cancer. Birth defects and laboratory features are characteristic and helpful in diagnosis, when present. Chromosome fragility is pathognomonic in the diagnosis. However, in some cases, there are no obvious physical anomalies or suggestive hematologic abnormalities, and inconclusive diagnostic tests have also been described. In such cases, a molecular diagnosis is required. This approach presents some advantages, especially in populations with a high incidence of FA and of consanguinity. Herein, we present a case with mild phenotypic features, inconclusive hematological findings and a negative breakage test. The diagnosis of FA was confirmed with next-generation sequencing. To our knowledge, this is the first publication of a FA patient being molecularly diagnosed utilizing this method since its introduction. Given its technical and financial features, we suggest that next-generation sequencing might be an alternative first-line diagnostic test for selected cases from particular populations.

PDF

___

1. Dokal I. Fanconi’s anaemia and related bone marrow failure syndromes. Br Med Bull 2006; 77-78: 37-53.

2. Eiler ME, Frohnmayer D, Frohnmayer L, Larsen K, Owen J (eds). Fanconi Anemia: Guidelines for Diagnosis and Management (3rd ed). Eugene, OR: Fanconi Anemia Research Fund, Inc.; 2008.

3. Alter BP. Modulation of macrocytosis in aplastic anemia. Am J Hematol 1998; 57: 92.

4. Alter BP. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program 2007: 29-39.

5. New HV, Cale CM, Tischkowitz M, et al. Nijmegen breakage syndrome diagnosed as Fanconi anaemia. Pediatr Blood Cancer 2005; 44: 494-499.

6. Auerbach AD. Fanconi anemia and its diagnosis. Mutat Res 2009; 668: 4-10.

7. Gallego MS, Barreiro CZ, Danielian S, Rosenweig SD. Positive diepoxybutane test in a patient with Nijmegen breakage syndrome. Pediatr Blood Cancer 2007; 49: 110.

8. Dokal I, Chase A, Morgan NV, et al. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi’s anaemia complementation group C mutations. Br J Haematol 1996; 93: 813-816.

9. Ameziane N, Sie D, Dentro S, et al. Diagnosis of Fanconi anemia: mutation analysis by next-generation sequencing. Anemia 2012; 2012: 132856.